Previous studies have shown that both Kras mutations and inflammation are essential for the development of pancreatic cancer [4]: inflammatory stimulation suppresses oncogene-induced cellular senescence in Kras mutant pancreatic cells, leading to Pancreatic intraepithelial neoplasia (PanIN) progression and pancreatic cancer [22]. The gene discussed is KRAS; the disease is pancreatic neoplasm.